Inhibition of Peptidylglycine
R
-Amidating Monooxygenase
A R T I C L E S
Others include R,â-unsaturated acids,20-22 a peptide terminating
in R-vinylglycine,23 and diastereomers of a peptide terminating
in an R-styrylglycine.24 These are all mechanism-based inhibitors
in that they show turnover-dependent inactivation of the enzyme.
Inhibitors of other types have also been reported, such as
inorganic sulfite,25 benzyl hydrazine,26 and N-formylamides,27
as well as derivatives of â-mercaptostyrene28 and homocys-
teine.29
to identify and characterize the precatalytic complex of PHM
with copper, oxygen, and the substrate. That study was the first
to delineate the role of copper in the activation of dioxygen in
this or any other enzyme system. The authors also drew a
correlation between the reactivity of PHM substrates and the
stability of the corresponding radical intermediates. They
reported that our earlier theoretical studies37 showed a peptide
R-carbon-centered alanyl radical to be 9.1 kJ mol-1 less stable
than a corresponding glycyl radical and noted that, even so,
N-acetyl-(S)-tryptophanyl-(R)-alanine is still processed by the
enzyme during X-ray diffraction. They also predicted, on the
basis of our calculations with related amino acids, that an
R-carbon-centered threonyl radical would be even less stable
than an alanyl radical, and accordingly found that a peptide
containing (R)-threonine instead of (R)-alanine at the C-terminus
was less effectively turned over by the enzyme. Our calculations
of glycyl and alanyl radical stability37 were based on the radicals
3c and 5d (Chart 1). Contrary to the above discussion, their
relative radical stabilization energies (RSEs), which correspond
to the negative of the relative bond dissociation energies of the
corresponding closed-shell molecules, actually showed the alanyl
radical 5d to be less stable than the glycyl radical 3c by only
1.6 kJ mol-1. We have not studied threonine derivatives, but
Rauk et al.39 used two different methods to calculate that an
R-carbon-centered threonyl radical is destabilized relative to a
glycyl radical by only 7-14 kJ mol-1. Consequently, the
destabilization of alanyl and threonyl radicals appears to have
been somewhat over-estimated by Prigge et al.,32 with the result
that the relationship between the stabilization energies of radicals
and the ease of their formation through PAM catalysis warrants
further investigation. We also include in the present study a
further comparison with the relative rates of formation of
radicals in conventional brominations.
PAM consists of two functional subunits, peptidylglycine
R-hydroxylating monooxygenase (PHM, E.C. 1.14.17.3) and
peptidylamidoglycolate lyase (PAL, E.C. 4.3.2.5.) (Scheme 1).
PHM catalyzes the copper-, molecular oxygen-, and ascorbate-
dependent hydroxylation of a C-terminal glycine residue of a
peptide substrate. The product hydroxyglycine is then hydro-
lyzed to the corresponding amide and glyoxylate, a process that
is catalyzed by PAL at physiological pH. The determination of
the crystal structure of PHM in both reduced and oxidized
forms,30-32 and kinetic33-35 and mutagenesis studies,36 have
resulted in a detailed picture of the mechanism of action of this
enzyme. In particular, it has been concluded that, in the first
step, a copper-bound superoxide radical abstracts the pro-S
hydrogen from the glycine residue, to give a glycyl radical.
In the present work we have sought to exploit factors affecting
the formation of such radicals in order to design analogues of
the substrates of PAM that competitively bind to, but are not
processed by, the enzyme and therefore inhibit reaction of the
substrates. To this end, we have compared the results of ab initio
calculations and studies of relative reaction rates in free radical
brominations, which identify factors affecting the stability and
ease of formation of glycyl and related radicals,37,38 with the
kinetic parameters defining the interactions of analogous
compounds with PAM.
Publication of our results is very timely in the light of a quite
recent paper by Prigge et al.,32 in which crystallography of
frozen protein soaked with a slowly reacting substrate was used
Results
The natural substrates of PAM all have in common an
N-acylated glycine, and they are therefore comprised of acyl,
amido, methylene, and carboxyl groups. Since the carboxyl
group of a substrate is known to be important for binding to
PAM,31 we have not examined alternatives to this moiety in
the present study. However, the effect of modifying each of
the other groups was explored. A range of N-acyl substituents
was investigated, since these are known to affect the stability
and ease of formation of glycyl radicals38,40 and to be tolerated
by PAM. Although derivatives of R-substituted amino acids tend
not to bind to PAM, small R-alkyl substituents, such as the
methyl group of (R)-alanine,32,41 the vinyl moiety of (R)-
vinylglycine,42 and the hydroxyethyl group of (R)-threonine,32
are accommodated. The incorporation of a trifluoromethyl group
was therefore studied since â,â,â-trifluoroalanine derivatives
are known to be resistant to R-carbon-centered radical forma-
tion.37 The effect of replacing the amido group with an ester or
ketone using derivatives of glycolate or γ-keto acids instead of
N-acylglycines was also explored. Glycolate inhibitors of PAM
have been previously reported22,42 in studies of broad ranges of
(19) Ogonowski, A. A.; May, S. W.; Moore, A. B.; Barrett, L. T.; O’Bryant, C.
L.; Pollock, S. H. J. Pharmacol. Exp. Ther. 1997, 280, 846-853.
(20) Feng, J.; Shi, J.; Sirimanne, S. R.; Mounier-Lee, C. E.; May, S. W. Biochem.
J. 2000, 350, 521-530.
(21) Moore, A. B.; May, S. W. Biochem. J. 1999, 341, 33-40.
(22) Katopodis, A. G.; May, S. W. Biochemistry 1990, 29, 4541-4548.
(23) Zabriskie, T. M.; Cheng, H. M.; Vederas, J. C. J. Am. Chem. Soc. 1992,
114, 2270-2272.
(24) Andrews, M. D.; O’Callaghan, K. A.; Vederas, J. C. Tetrahedron 1997,
53, 8295-8306.
(25) Merkler, D. J.; Kulathila, R.; Francisco, W. A.; Ash, D. E.; Bell, J. FEBS
Lett. 1995, 366, 165-169.
(26) Merkler, D. J.; Kulathila, R.; Ash, D. E. Arch. Biochem. Biophys. 1995,
317, 93-102.
(27) Klinge, M.; Cheng, H. M.; Zabriskie, T. M.; Vederas, J. C. J. Chem. Soc.,
Chem. Commun. 1994, 1379-1380.
(28) Casara, P.; Ganzhorn, A.; Philippo, C.; Chanal, M. C.; Danzin, C. Bioorg.
Med. Chem. Lett. 1996, 6, 393-396.
(29) Erion, M. D.; Tan, J.; Wong, M.; Jeng, A. Y. J. Med. Chem. 1994, 37,
4430-4437.
(30) Prigge, S. T.; Kolhekar, A. S.; Eipper, B. A.; Mains, R. E.; Amzel, L. M.
Nat. Struct. Biol. 1999, 6, 976-983.
(31) Prigge, S. T.; Kolhekar, A. S.; Eipper, B. A.; Mains, R. E.; Amzel, L. M.
Science 1997, 278, 1300-1305.
(32) Prigge, S. T.; Eipper, B. A.; Mains, R. E.; Amzel, L. M. Science 2004,
304, 864-867.
(33) Francisco, W. A.; Merkler, D. J.; Blackburn, N. J.; Klinman, J. P.
Biochemistry 1998, 37, 8244-8252.
(34) Francisco, W. A.; Knapp, M. J.; Blackburn, N. J.; Klinman, J. P. J. Am.
Chem. Soc. 2002, 124, 8194-8195.
(35) Francisco, W. A.; Blackburn, N. J.; Klinman, J. P. Biochemistry 2003, 42,
1813-1819.
(39) Rauk, A.; Yu, D.; Taylor, J.; Shustov, G. V.; Block, D. A.; Armstrong, D.
A. Biochemistry 1999, 38, 9089-9096.
(36) Bell, J.; El Meskini, R.; D’Amato, D.; Mains, R. E.; Eipper, B. A.
Biochemistry 2003, 42, 7133-7142.
(40) Easton, C. J. Chem. ReV. 1997, 97, 53-82.
(41) Landymore-Lim, A. E. N.; Bradbury, A. F.; Smyth, D. G. Biochem. Biophys.
Res. Commun. 1983, 117, 289-293.
(37) Croft, A. K.; Easton, C. J.; Radom, L. J. Am. Chem. Soc. 2003, 125, 4119-
4124.
(38) Croft, A. K.; Easton, C. J.; Kociuba, K.; Radom, L. Tetrahedron:
Asymmetry 2003, 14, 2919-2926.
(42) Ping, D.; Mounier, C. E.; May, S. W. J. Biol. Chem. 1995, 270, 29250-
29255.
9
J. AM. CHEM. SOC. VOL. 126, NO. 41, 2004 13307